Acute kidney injury and mortality risk in older adults with COVID-19.


Journal

Journal of nephrology
ISSN: 1724-6059
Titre abrégé: J Nephrol
Pays: Italy
ID NLM: 9012268

Informations de publication

Date de publication:
04 2021
Historique:
received: 29 12 2020
accepted: 07 03 2021
pubmed: 23 3 2021
medline: 22 4 2021
entrez: 22 3 2021
Statut: ppublish

Résumé

Research regarding COVID-19 and acute kidney injury (AKI) in older adults is scarce. We evaluated risk factors and outcomes of AKI in hospitalized older adults with and without COVID-19. Observational study of patients admitted to two geriatric clinics in Stockholm from March 1st to June 15th, 2020. The difference in incidence, risk factors and adverse outcomes for AKI between patients with or without COVID-19 were examined. Odds ratios (OR) for the risk of AKI and in-hospital death were obtained from logistic regression. Three hundred-sixteen older patients were hospitalized for COVID-19 and 876 patients for non-COVID-19 diagnoses. AKI occurred in 92 (29%) patients with COVID-19 vs. 159 (18%) without COVID-19. The odds for developing AKI were higher in patients with COVID-19 (adjusted OR, 1.70; 95% confidence interval [CI] 1.04-2.76), low baseline kidney function as depicted by estimated glomerular filtration rate (eGFR) [4.19 (2.48-7.05), for eGFR 30 to  < 60 mL/min, and 20.3 (9.95-41.3) for eGFR < 30 mL/min], and higher C reactive protein (CRP) (OR 1.81 (1.11-2.95) in patients with initial CRP > 10 mg/L). Compared to patients without COVID-19 and without AKI, the risk of in-hospital death was highest in patients with COVID-19 and AKI [OR 80.3, 95% CI (27.3-235.6)], followed by COVID-19 without AKI [16.3 (6.28-42.4)], and by patients without COVID-19 and with AKI [10.2 (3.66-28.2)]. Geriatric patients hospitalized with COVID-19 had a higher incidence of AKI compared to patients hospitalized for other diagnoses. COVID-19 and reduced baseline kidney function were risk factors for developing AKI. AKI and COVID-19 were associated with in-hospital death.

Sections du résumé

BACKGROUND
Research regarding COVID-19 and acute kidney injury (AKI) in older adults is scarce. We evaluated risk factors and outcomes of AKI in hospitalized older adults with and without COVID-19.
METHODS
Observational study of patients admitted to two geriatric clinics in Stockholm from March 1st to June 15th, 2020. The difference in incidence, risk factors and adverse outcomes for AKI between patients with or without COVID-19 were examined. Odds ratios (OR) for the risk of AKI and in-hospital death were obtained from logistic regression.
RESULTS
Three hundred-sixteen older patients were hospitalized for COVID-19 and 876 patients for non-COVID-19 diagnoses. AKI occurred in 92 (29%) patients with COVID-19 vs. 159 (18%) without COVID-19. The odds for developing AKI were higher in patients with COVID-19 (adjusted OR, 1.70; 95% confidence interval [CI] 1.04-2.76), low baseline kidney function as depicted by estimated glomerular filtration rate (eGFR) [4.19 (2.48-7.05), for eGFR 30 to  < 60 mL/min, and 20.3 (9.95-41.3) for eGFR < 30 mL/min], and higher C reactive protein (CRP) (OR 1.81 (1.11-2.95) in patients with initial CRP > 10 mg/L). Compared to patients without COVID-19 and without AKI, the risk of in-hospital death was highest in patients with COVID-19 and AKI [OR 80.3, 95% CI (27.3-235.6)], followed by COVID-19 without AKI [16.3 (6.28-42.4)], and by patients without COVID-19 and with AKI [10.2 (3.66-28.2)].
CONCLUSIONS
Geriatric patients hospitalized with COVID-19 had a higher incidence of AKI compared to patients hospitalized for other diagnoses. COVID-19 and reduced baseline kidney function were risk factors for developing AKI. AKI and COVID-19 were associated with in-hospital death.

Identifiants

pubmed: 33751497
doi: 10.1007/s40620-021-01022-0
pii: 10.1007/s40620-021-01022-0
pmc: PMC7982881
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

295-304

Subventions

Organisme : Svenska Forskningsrådet Formas (SE)
ID : 2016-02317

Références

Kunutsor SK, Laukkanen JA (2020) Renal complications in COVID-19: a systematic review and meta-analysis. Ann Med. https://doi.org/10.1080/07853890.2020.1790643
doi: 10.1080/07853890.2020.1790643 pubmed: 32840381 pmcid: 7877981
Lim MA et al (2020) Multiorgan failure with emphasis on acute kidney injury and severity of covid-19: systematic review and meta-analysis. Can J Kidney Health Dis 7:2054358120938573. https://doi.org/10.1177/2054358120938573
doi: 10.1177/2054358120938573 pubmed: 32685180 pmcid: 7343353
Brienza N, Puntillo F, Romagnoli S, Tritapepe L (2020) Acute kidney injury in coronavirus disease 2019 infected patients: a meta-analytic study. Blood Purif. https://doi.org/10.1159/000509274
doi: 10.1159/000509274 pubmed: 32615555 pmcid: 7445379
Fu EL et al (2020) Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis. Clin Kidney J 13:550–563. https://doi.org/10.1093/ckj/sfaa160
doi: 10.1093/ckj/sfaa160 pubmed: 32897278 pmcid: 7467593
Yang X et al (2020) Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis. Critical Care (London, England) 24:356. https://doi.org/10.1186/s13054-020-03065-4
doi: 10.1186/s13054-020-03065-4
Ronco C, Reis T, Husain-Syed F (2020) Management of acute kidney injury in patients with COVID-19. Lancet Respir Med 8:738–742. https://doi.org/10.1016/s2213-2600(20)30229-0
doi: 10.1016/s2213-2600(20)30229-0 pubmed: 32416769 pmcid: 7255232
Angel-Korman A, Brosh T, Glick K, Leiba A (2020) COVID-19, THE KIDNEY AND HYPERTENSION. Harefuah 159:231–234
pubmed: 32307955
Farouk SS, Fiaccadori E, Cravedi P, Campbell KN (2020) COVID-19 and the kidney: what we think we know so far and what we don’t. J Nephrol. https://doi.org/10.1007/s40620-020-00789-y
doi: 10.1007/s40620-020-00789-y pubmed: 32691342 pmcid: 7370875
Gabarre P et al (2020) Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med 46:1339–1348. https://doi.org/10.1007/s00134-020-06153-9
doi: 10.1007/s00134-020-06153-9 pubmed: 32533197
Hansrivijit P et al (2020) Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis. J Investig Med. https://doi.org/10.1136/jim-2020-001407
doi: 10.1136/jim-2020-001407 pubmed: 32655013 pmcid: 7371487
Ali H et al (2020) Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis. Ren Fail 42:393–397. https://doi.org/10.1080/0886022x.2020.1756323
doi: 10.1080/0886022x.2020.1756323 pubmed: 32340507 pmcid: 7241495
Robbins-Juarez SY et al (2020) Outcomes for patients with COVID-19 and acute kidney injury: a systematic review and meta-analysis. Kidney Int Rep 5:1149–1160. https://doi.org/10.1016/j.ekir.2020.06.013
doi: 10.1016/j.ekir.2020.06.013 pubmed: 32775814 pmcid: 7314696
Yan Q et al (2020) Acute kidney injury is associated with in-hospital mortality in older patients with COVID-19. J Gerontol Ser A Biol Sci Med Sci. https://doi.org/10.1093/gerona/glaa181
doi: 10.1093/gerona/glaa181
Nimkar A et al (2020) Incidence and risk factors for acute kidney injury and its effect on mortality in patients hospitalized from Covid-19. Mayo Clin Proc Innov Qual Outcomes. https://doi.org/10.1016/j.mayocpiqo.2020.07.003
doi: 10.1016/j.mayocpiqo.2020.07.003 pubmed: 32838205 pmcid: 7368916
Hirsch JS et al (2020) Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 98:209–218. https://doi.org/10.1016/j.kint.2020.05.006
doi: 10.1016/j.kint.2020.05.006 pubmed: 32416116 pmcid: 7229463
Cheng Y et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97:829–838. https://doi.org/10.1016/j.kint.2020.03.005
doi: 10.1016/j.kint.2020.03.005 pubmed: 32247631 pmcid: 7110296
Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12–March 16, 2020. MMWR Morbid Mortal Wkly Rep 69:343–346. https://doi.org/10.15585/mmwr.mm6912e2
Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. https://doi.org/10.1001/jama.2020.4683
doi: 10.1001/jama.2020.4683 pubmed: 32203977
Zhu N et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733. https://doi.org/10.1056/NEJMoa2001017
doi: 10.1056/NEJMoa2001017 pubmed: 7092803 pmcid: 7092803
Romero Starke K et al (2020) The age-related risk of severe outcomes due to COVID-19 infection: a rapid review, meta-analysis, and meta-regression. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph17165974
doi: 10.3390/ijerph17165974 pubmed: 33327657 pmcid: 7765156
Ludvigsson JF (2020) The first eight months of Sweden’s COVID-19 strategy and the key actions and actors that were involved. Acta Paediatr (Oslo, Norway; 1992). https://doi.org/10.1111/apa.15582
doi: 10.1111/apa.15582
Ludvigsson JF et al (2011) External review and validation of the Swedish national inpatient register. BMC Public Health 11:450. https://doi.org/10.1186/1471-2458-11-450
doi: 10.1186/1471-2458-11-450 pubmed: 21658213 pmcid: 3142234
Quan H et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139
doi: 10.1097/01.mlr.0000182534.19832.83
Levey AS et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
doi: 10.7326/0003-4819-150-9-200905050-00006
Siew ED, Matheny ME (2015) Choice of reference serum creatinine in defining acute kidney injury. Nephron 131:107–112. https://doi.org/10.1159/000439144
doi: 10.1159/000439144 pubmed: 26332325 pmcid: 4618709
Fisher M et al (2020) AKI in hospitalized patients with and without COVID-19: a comparison study. J Am Soc Nephrol JASN. https://doi.org/10.1681/asn.2020040509
doi: 10.1681/asn.2020040509 pubmed: 32669322
(2012) Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004) Acute renal failure— definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care (London, England) 8:R204-212. https://doi.org/10.1186/cc2872
doi: 10.1186/cc2872
Grams ME et al (2015) A Meta-analysis of the association of estimated GFR, albuminuria, age, race, and sex with acute kidney injury. Am J Kidney Dis 66:591–601. https://doi.org/10.1053/j.ajkd.2015.02.337
doi: 10.1053/j.ajkd.2015.02.337 pubmed: 25943717 pmcid: 4584180
Su H et al (2020) Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98:219–227. https://doi.org/10.1016/j.kint.2020.04.003
doi: 10.1016/j.kint.2020.04.003 pubmed: 32327202 pmcid: 7194105
Kudose S et al (2020) Kidney biopsy findings in patients with COVID-19. J Am Soc Nephrol JASN. https://doi.org/10.1681/asn.2020060802
doi: 10.1681/asn.2020060802 pubmed: 32938647
Chiappelli F, Khakshooy A, Greenberg G (2020) CoViD-19 immunopathology and immunotherapy. Bioinformation 16:219–222. https://doi.org/10.6026/97320630016219
doi: 10.6026/97320630016219 pubmed: 32308263 pmcid: 7147500
Flythe JE et al (2020) Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States. Am J Kidney Dis. https://doi.org/10.1053/j.ajkd.2020.09.003
doi: 10.1053/j.ajkd.2020.09.003 pubmed: 32961244 pmcid: 7222427
Duggal A, Pinto R, Rubenfeld G, Fowler RA (2016) Global variability in reported mortality for critical illness during the 2009–10 influenza A(H1N1) pandemic: a systematic review and meta-regression to guide reporting of outcomes during disease outbreaks. PLoS ONE 11:e0155044. https://doi.org/10.1371/journal.pone.0155044
doi: 10.1371/journal.pone.0155044 pubmed: 27170999 pmcid: 4865181
Chen YT, Shao SC, Lai EC, Hung MJ, Chen YC (2020) Mortality rate of acute kidney injury in SARS, MERS, and COVID-19 infection: a systematic review and meta-analysis. Crit Care (London, England) 24:439. https://doi.org/10.1186/s13054-020-03134-8
doi: 10.1186/s13054-020-03134-8

Auteurs

Hong Xu (H)

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO, Blickagången 16, Huddinge, 141 52, Stockholm, Sweden. hong.xu.2@ki.se.

Sara Garcia-Ptacek (S)

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO, Blickagången 16, Huddinge, 141 52, Stockholm, Sweden.
Theme Aging, Karolinska University Hospital, Stockholm, Sweden.

Martin Annetorp (M)

Theme Aging, Karolinska University Hospital, Stockholm, Sweden.

Annette Bruchfeld (A)

Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
Department of Renal Medicine, Karolinska University Hospital, Stockholm, Sweden.

Tommy Cederholm (T)

Theme Aging, Karolinska University Hospital, Stockholm, Sweden.
Clinical Nutrition and Metabolism, Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.

Peter Johnson (P)

Department of Geriatrics, Capio Geriatrik Nacka AB, Nacka, Sweden.

Miia Kivipelto (M)

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO, Blickagången 16, Huddinge, 141 52, Stockholm, Sweden.
Theme Aging, Karolinska University Hospital, Stockholm, Sweden.

Carina Metzner (C)

Theme Aging, Karolinska University Hospital, Stockholm, Sweden.

Dorota Religa (D)

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO, Blickagången 16, Huddinge, 141 52, Stockholm, Sweden.
Theme Aging, Karolinska University Hospital, Stockholm, Sweden.

Maria Eriksdotter (M)

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO, Blickagången 16, Huddinge, 141 52, Stockholm, Sweden.
Theme Aging, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH